Clinical Trials Directory

Trials / Completed

CompletedNCT02402270

Safety and Tolerability Study of an Edible Colon Preparation

An Adaptive, Single-Blind, Parallel, Randomized, Phase 2, Formulation Screening/Proof of Concept, Safety, Tolerability and Efficacy Study of Three Formulations/Dosing Regimens of ECP (PEG 3350) Colon Prep Kit Compared to Comparators.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
69 (actual)
Sponsor
ColonaryConcepts LLC · Industry
Sex
All
Age
18 Years – 74 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to learn about a new bowel preparation that uses food to clean the colon. In order to learn about this new food preparation, some people in this study will get the food preparation, and others will get the standard liquid bowel preparation. Patients will be randomized (like flipping a coin) to one of five groups: Group 1 - Menu A Meal Kit - contains bars, shakes, soup, and a rice bowl Group 2 - Menu B Meal Kit - contains bars, shakes, soup, and a rice bowl Group 3 - Menu C Meal Kit - contains bars and shakes Group 4 - MoviPrep Group 5 - NuLYTELY

Detailed description

The purpose of this Phase 2 formulation screening/proof of concept study is to evaluate the safety, tolerability, and efficacy of up to 3 ECP-019 formulations/dosing regimens comprising a PEG 3350 Colon Prep Kit, containing electrolytes provided by the foods, in 3 formulations/ dosing regimens as compared to 2 comparators in a Phase 2 study.

Conditions

Interventions

TypeNameDescription
DRUGNuLYTELY® (PEG 3350)
DRUGECP-019
DRUGMoviPrep® (PEG 3350)

Timeline

Start date
2015-05-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-03-30
Last updated
2018-01-29

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02402270. Inclusion in this directory is not an endorsement.